Table 5.
VDR rs4516035 genotype |
Sun exposure at 13–21
|
Ordinal sun OR (95 % CI)b | p interactionc | |||||||
---|---|---|---|---|---|---|---|---|---|---|
≤3 h/week (reference)
|
4–7 h/week
|
8–14 h/week
|
≥15 h/week
|
|||||||
Nco/Nca | OR (95 % CI) | Nco/Nca | OR (95 % CI) | Nco/Nca | OR (95 % CI) | Nco/Nca | OR (95 % CI) | |||
All NHL (n = 576)a | ||||||||||
AA | 19/14 | 1.0 (ref) | 43/43 | 1.49 (0.66, 3.38) | 142/73 | 0.70 (0.33, 1.49) | 117/40 | 0.42 (0.19, 0.93) | 0.66 (0.53, 0.83) | |
AG + GG | 39/23 | 0.83 (0.35, 1.98) | 112/74 | 0.88 (0.41, 1.87) | 278/177 | 0.84 (0.41, 1.73) | 235/132 | 0.71 (0.34, 1.48) | 0.92 (0.79, 1.07) | 0.0063 |
Diffuse large B-cell lymphoma (n = 99) | ||||||||||
AA | 19/3 | 1.00 (ref) | 43/6 | 0.95 (0.21, 4.23) | 142/9 | 0.44 (0.11, 1.77) | 117/8 | 0.46 (0.11, 1.92) | 0.70 (0.45, 1.11) | |
AG + GG | 39/5 | 0.81 (0.17, 3.77) | 112/13 | 0.77 (0.20, 2.98) | 278/28 | 0.68 (0.19, 2.48) | 235/27 | 0.78 (0.21, 2.86) | 1.01 (0.76, 1.34) | 0.23 |
Follicular lymphoma (n = 144) | ||||||||||
AA | 19/2 | 1.00 (ref) | 43/10 | 2.19 (0.43,11.03) | 142/28 | 1.95 (0.43, 8.92) | 117/8 | 0.70 (0.14, 3.58) | 0.80 (0.56, 1.16) | |
AG + GG | 39/3 | 0.73 (0.11, 4.79) | 112/13 | 1.04 (0.22, 5.04) | 278/49 | 1.70 (0.38, 7.62) | 235/31 | 1.33 (0.29, 6.05) | 1.12 (0.86, 1.46) | 0.066 |
Small lymphocytic lymphoma/chronic lymphocytic leukemia (n = 195) | ||||||||||
AA | 19/5 | 1.00 (ref) | 43/12 | 1.30 (0.39, 4.30) | 142/24 | 0.64 (0.21, 1.94) | 117/16 | 0.43 (0.14, 1.37) | 0.65 (0.46, 0.92) | 0.33 |
AG + GG | 39/6 | 0.66 (0.17, 2.49) | 112/31 | 1.08 (0.36, 3.20) | 278/60 | 0.79 (0.27, 2.25) | 235/41 | 0.57 (0.19, 1.67) | 0.83 (0.67, 1.04) |
Sample size listed are the numbers of subjects with all data available and therefore included in this analysis of interaction
All models adjusted for age, gender, and family history of NHL
All interaction p values are based upon a likelihood ratio test and treat sun exposure as ordinal